NEHABAHEN SHAH: Open Payments
NPI 1932388931 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 46 payments from 11 companies in 2025. Trend: 2023 $587 · 2024 $707 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $176 |
| AstraZeneca Pharmaceuticals LP | 11 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $123 |
| Exact Sciences Corporation | 4 | $79 |
| PFIZER INC. | 4 | $66 |
| Lilly USA, LLC | 3 | $50 |
| Abbott Laboratories | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: Kerendia, FARXIGA, Rybelsus, BREZTRI, Cologuard Collection Kit, Wegovy, Ozempic, FREESTYLE LIBRE 3.
Industry payments across NJ — which companies pay providers there.
